Marcus J. Couch1,2, Felipe Morgado1,2, Nikhil Kanhere1, Krzysztof Kowalik1, Jonathan Rayment3, Felix Ratjen1,3, and Giles Santyr1,2
1Translational Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 2Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada, 3Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada
Synopsis
The lung clearance index, measured using N2
multiple breath washout (MBW), provides an indicator of ventilation
heterogeneity but lacks regional information. The combination of MBW and
hyperpolarized 129Xe MRI can potentially provide measurements of
ventilation heterogeneity that include both spatial and temporal information.
MBW imaging was performed following an initial 129Xe inhalation and
during multiple breath-holds of room air to measure the 129Xe
washout. Fractional ventilation and coefficient of variation maps measured in
pediatric cystic fibrosis participants show elevated ventilation heterogeneity
compared to age-matched healthy controls.
Introduction
Multiple breath washout (MBW) is a test that can be used to derive the
lung clearance index (LCI), which is sensitive to ventilation heterogeneity and
early lung disease.1 Although LCI is more
sensitive than clinically used spirometric indices, such as the forced
expiratory volume in one second (FEV1),2
both tests provide whole-lung measurements that cannot identify the specific lung
regions that contribute to the ventilation heterogeneity. Hyperpolarized (HP) 129Xe
MRI is a lung imaging technique that is feasible in children with CF,3 and images can be
quantified using the ventilation defect percent (VDP).4 The combination of
MBW with HP gas imaging can potentially provide both temporal and spatial washout
information.5 MBW imaging has been
performed in pediatric CF using HP 3He,6 but the feasibility
of HP 129Xe MBW imaging has not yet been demonstrated in a pediatric
population. The purpose of this study was to perform HP 129Xe MBW
MRI in pediatric CF, and to compare it to LCI and FEV1.Methods
Eleven pediatric participants were recruited
(mean age 11.4±2.4 years), including four with well-controlled CF and seven
aged-matched healthy controls. Standard pulmonary function tests were
performed, as well as N2 MBW (Exhalyzer D®, EcoMedics AG) to measure LCI (2.5%
threshold). Imaging was performed at 3T (Siemens Prisma) using a flexible 129Xe
vest coil (Clinical MR Solutions). 129Xe was polarized (Polarean, Durham, NC) and dosed at 10% of total lung
capacity (balanced with N2 in a 1L dose bag). Following the
method of Horn et al.,5 the 129Xe
dose was inhaled from functional residual capacity, and two 129Xe
images (separated by a 5s delay) were acquired to correct for RF- and T1-induced
signal decay. The participant exhaled, inhaled room air, held their breath, and
repeated this procedure as a series of 4–6 washout images were acquired. Each image
was a 2D projection acquired in the coronal plane (gradient echo, TR=8.1ms,
TE=1.9ms, FA=4°, FOV=480x480mm2, matrix=64x64, and BW=100Hz/pixel). Fractional ventilation, r, defined as the fractional gas
replacement per breath, was calculated using previously described MBW signal
equations.5 To assess ventilation
heterogeneity, coefficient of variation (CV) maps were calculated from the r maps.7Results
There was a statistically significant difference in
LCI between the CF and healthy groups (9.5±1.9 and 6.9±0.6, respectively, p=0.02 from a Wilcoxon rank-sum test),
but FEV1 was not statistically different (103±11% and 112±16%,
respectively, p=0.22). Figure 1 shows two representative series of HP 129Xe
MBW images acquired in a healthy participant and in a CF patient. Corresponding
r and CV maps calculated from Fig. 1
are shown in Fig. 2. CF participants had a mean r of 0.51±0.07 while healthy participants had a mean r of 0.42±0.11 (p=0.07). r was not correlated
with FEV1 (R2=4.1x10-5), but it may be very
weakly correlated with LCI (R2=0.15). CF participants had a mean CV
of 0.14±0.08 and healthy participants had a mean CV of 0.09±0.02. Although the
differences in CV were not significant between groups (p=0.51), there was a weak
correlation between CV and both FEV1 (R2=0.34) and LCI (R2=0.34)
(Fig. 3).Discussion
There
was a trend in this study towards increasing mean r in CF subjects compared to healthy controls, which was an
unexpected result given the increase in both VDP and LCI previously measured in
a similar pediatric population.8
One possible explanation for this finding is that HP 129Xe MBW imaging uses a single breath washin
prior to imaging. Therefore, the 129Xe gas may not have been able to
fully equilibrate in the most obstructed areas of the lung before the washout
breaths. Therefore, MBW imaging results may represent the washout kinetics of better-ventilated
regions of the lung, contributing to higher observed r in CF lungs that have overall worse ventilation heterogeneity.
This
study also showed a trend towards increased CV in CF, and a weak correlation between
CV and both FEV1 and LCI. Therefore, CV may
be more reflective of the underlying physiologic abnormalities seen in CF than r alone. There were a
few limitations in this study, such as the use of 2D projection imaging, which may
cause partial volume artifacts that add additional weighting to r maps. In addition, this study assumed
a constant 5s delay, constant tidal volume, and constant T1 for each
washout breath; therefore, poor subject compliance and changes in T1
due to an increasing oxygen partial pressure with each washout breath will also
bias r maps.
Conclusions
This study demonstrates that HP 129Xe MBW imaging is feasible
in pediatric participants with CF. Mapping ventilation heterogeneity using HP 129Xe
MRI is expected to provide a useful tool for detecting functional changes that
result from both disease progression and treatment response in early CF lung
disease.Acknowledgements
We thank Tammy Rayner and Ruth Weiss for assistance
with MRI data acquisition. This work was funded in part by a Cystic Fibrosis
Research Catalyst from The Hospital for Sick Children, a Canadian Institutes
for Health Research (CIHR) operating grant (MOP 123431), and a Natural Sciences
and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN
217015-2013). MJC was funded by a Restracomp fellowship award from The Hospital
for Sick Children, and a Mitacs Elevate postdoctoral fellowship.References
1. Gustafsson PM, Aurora P, Lindblad A. Evaluation of
ventilation maldistribution as an early indicator of lung disease in children
with cystic fibrosis. Eur Respir J 2003;22(6):972-979.
2. Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price
J, Stroobant J, Carr S, Stocks J. Multiple-breath washout as a marker of lung
disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med
2005;171(3):249-256.
3. Walkup LL, Thomen RP, Akinyi TG, Watters E, Ruppert K,
Clancy JP, Woods JC, Cleveland ZI. Feasibility, tolerability and safety of
pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers
and children with cystic fibrosis. Pediatr Radiol 2016;46(12):1651-1662.
4. Thomen RP, Walkup LL, Roach DJ, Cleveland ZI, Clancy JP,
Woods JC. Hyperpolarized 129Xe for investigation of mild cystic fibrosis lung
disease in pediatric patients. J Cyst Fibros 2017;16(2):275-282.
5. Horn FC, Deppe MH, Marshall H, Parra-Robles J, Wild JM.
Quantification of regional fractional ventilation in human subjects by
measurement of hyperpolarized 3He washout with 2D and 3D MRI. J Appl Physiol
2014;116(2):129-139.
6. Horn FC, Marshall H, Siddiqui S, Horsley A, Smith L, Aldag
I, Kay R, Taylor CJ, Parra-Robles J, Wild JM. Ventilation heterogeneity in
obstructive airways disease – comparing multi-breath washout-imaging with
global lung measurements. Proc ISMRM 2015;23:852.
7. Tzeng YS, Lutchen K, Albert M. The difference in
ventilation heterogeneity between asthmatic and healthy subjects quantified
using hyperpolarized 3He MRI. J Appl Physiol 2009;106:813-822.
8. Kanhere N, Couch MJ, Kowalik K, Zanette B, Rayment JH,
Manson D, Subbarao P, Ratjen F, Santyr G. Correlation of Lung Clearance Index
with Hyperpolarized 129Xe Magnetic Resonance Imaging in Pediatric Subjects with
Cystic Fibrosis. Am J Respir Crit Care Med 2017;196(8):1073-1075.